XML 40 R30.htm IDEA: XBRL DOCUMENT v3.21.2
Equity-based Compensation - Summary of Equity Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2021
Dec. 31, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Number of Shares, Granted 28,250 140,569  
2013 and 2019 Equity Incentive Plan      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Number of Shares, Beginning balance   4,121,225  
Number of Shares, Granted   140,569  
Number of Shares, Exercised   (1,448,061)  
Number of Shares, Forfeited   (42,878)  
Number of Shares, Expired   (2,816)  
Number of Shares, Ending balance 2,768,039 2,768,039 4,121,225
Number of Shares, Exercisable 813,278 813,278  
Number of Shares, Vested and expected to vest 2,768,039 2,768,039  
Weighted Average Exercise Price, Beginning balance   $ 9.20  
Weighted Average Exercise Price, Granted   51.16  
Weighted Average Exercise Price, Exercised   6.53  
Weighted Average Exercise Price, Forfeited   15.69  
Weighted Average Exercise Price, Expired   15.62  
Weighted Average Exercise Price, Ending balance $ 12.62 12.62 $ 9.20
Weighted Average Exercise Price, Exercisable 10.00 10.00  
Weighted Average Exercise Price, Vested and expected to vest $ 12.62 $ 12.62  
Weighted Average Remaining Contractual Term   7 years 6 months 7 years
Weighted Average Remaining Contractual Term, Granted   9 years 6 months  
Weighted Average Remaining Contractual Term, Exercisable   6 years  
Weighted Average Remaining Contractual Term, Vested and expected to vest   7 years 6 months  
Aggregate Intrinsic Value, Balance $ 136,212 $ 136,212 $ 87,842
Aggregate Intrinsic Value, Exercisable 42,105 42,105  
Aggregate Intrinsic Value, Vested and expected to vest $ 136,212 $ 136,212